UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Probability of Cancer in Pulmonary Nodules Detected on First Screening CT

The New England journal of medicine, 2013-09, Vol.369 (10), p.910-919

2013

Volltextzugriff (PDF)

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

The New England journal of medicine, 2019-02, Vol.380 (8), p.711-719

2019

Volltextzugriff (PDF)

Role of Epidermal Growth Factor Receptor Inhibitors in Epidermal Growth Factor Receptor Wild-Type Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2013-03, Vol.31 (8), p.1061-1069

2013

Volltextzugriff (PDF)

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3320-3326

2013

Volltextzugriff (PDF)

Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2017-07, Vol.12 (7), p.1061-1070

2017

Volltextzugriff (PDF)

Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-03, Vol.29 (8), p.1059-1066

2011

Volltextzugriff (PDF)

Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer

PloS one, 2016-03, Vol.11 (3), p.e0150567-e0150567

2016

Volltextzugriff (PDF)

Drug resistance to molecular targeted therapy and its consequences for treatment decisions in non-small-cell lung cancer

Frontiers in oncology, 2014-01, Vol.4, p.190-190

2014

Volltextzugriff (PDF)

Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3

Clinical cancer research, 2017-08, Vol.23 (15), p.4501-4510

2017

Volltextzugriff (PDF)

Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer

Translational Lung Cancer Research, 2019-11, Vol.8 (S3), p.S247-S264

2019

Volltextzugriff (PDF)

Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study

The lancet oncology, 2017-11, Vol.18 (11), p.1523-1531

2017

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Inhibition in the Management of Squamous Cell Carcinoma of the Lung

The oncologist (Dayton, Ohio), 2016-02, Vol.21 (2), p.205-213

2016

Volltextzugriff (PDF)

Age and Comorbidity As Independent Prognostic Factors in the Treatment of Non–Small-Cell Lung Cancer: A Review of National Cancer Institute of Canada Clinical Trials Group Trials

Journal of clinical oncology, 2008-01, Vol.26 (1), p.54-59

2008

Volltextzugriff (PDF)

Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study

Journal of clinical oncology, 2010-01, Vol.28 (1), p.49-55

2010

Volltextzugriff (PDF)

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10

Journal of clinical oncology, 2010-01, Vol.28 (1), p.29-34

2010

Volltextzugriff (PDF)

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

The New England journal of medicine, 2005-06, Vol.352 (25), p.2589-2597

2005

Volltextzugriff (PDF)

CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLC

Journal of thoracic oncology, 2022-03, Vol.17 (3), p.434-445

2022

Volltextzugriff (PDF)

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease

Clinical & experimental metastasis, 2012-02, Vol.29 (2), p.123-132

2012

Volltextzugriff (PDF)

Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Journal of thoracic oncology, 2016-03, Vol.11 (3), p.312-323

2016

Volltextzugriff (PDF)

Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian Arctic

Current oncology (Toronto), 2022-04, Vol.29 (5), p.3171-3186

2022

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(177)

Publikationsform

Artikel
(183)
Buchkapitel
(2)

Sprache

Englisch
(184)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Life Sciences & Biomedicine
(107)
Humans
(101)
Oncology
(96)
Female
(61)
Male
(59)
Middle Aged
(59)
Lung Neoplasms - Drug Therapy
(50)
Aged
(49)
Biological And Medical Sciences
(48)
Medical Sciences
(47)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(44)
Adult
(35)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(28)
Lung Neoplasms - Pathology
(28)
Pharmacology. Drug Treatments
(27)
Pneumology
(26)
Tumors Of The Respiratory System And Mediastinum
(26)
Antineoplastic Agents
(25)
Tumors
(25)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

Probability of Cancer in Pulmonary Nodules Detected on First Screening CT

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

Role of Epidermal Growth Factor Receptor Inhibitors in Epidermal Growth Factor Receptor Wild-Type Non–Small-Cell Lung Cancer

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer

Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial

Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer

Drug resistance to molecular targeted therapy and its consequences for treatment decisions in non-small-cell lung cancer

Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3

Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer

Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study

Epidermal Growth Factor Receptor Inhibition in the Management of Squamous Cell Carcinoma of the Lung

Age and Comorbidity As Independent Prognostic Factors in the Treatment of Non–Small-Cell Lung Cancer: A Review of National Cancer Institute of Canada Clinical Trials Group Trials

Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLC

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease

Efficacy and safety results of depatuxizumab mafodotin (ABT‐414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor

Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian Arctic

A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226

Suchergebnisse filtern